WHO Guideline Advises Against Fluvoxamine, Colchicine for COVID-19
FRIDAY, July 15, 2022 (HealthDay News) — Fluvoxamine and colchicine are not recommended for nonsevere COVID-19, according to the 11th version of the World Health Organization living guideline on drugs for COVID-19 published online July 13 in The BMJ….
Learn MoreDon’t Use Luvox, Colchicine to Fight COVID, WHO Experts Say
FRIDAY, July 15, 2022 (HealthDay News) — People shouldn’t take the drugs colchicine and fluvoxamine to treat mild to moderate COVID-19, the World Health Organization (WHO) is warning.The antidepressant drug fluvoxamine (Luvox) and the gout drug colch…
Learn More‘Stepped’ Approach to Treating Diabetic Eye Disease May Be Best
FRIDAY, July 15, 2022 (HealthDay News) — An off-brand medication for diabetic macular edema might prove just as effective in early treatment as its more expensive alternative, potentially saving patients thousands of dollars, new research suggests.Th…
Learn MoreAsthma Drug Fluticasone Fails as Potential COVID-19 Treatment
THURSDAY, July 14, 2022 (HealthDay News) — The asthma drug fluticasone furoate is yet another medication that does not work for mild-to-moderate COVID-19, a new study finds. The study was published online July 13 in medRxiv, which publishes studies b…
Learn MoreSurvival Advantage Seen for A+ADV in Advanced Hodgkin Lymphoma
THURSDAY, July 14, 2022 (HealthDay News) — For patients with stage III or IV Hodgkin lymphoma, brentuximab vedotin is associated with a survival advantage, according to a study published online July 13 in the New England Journal of Medicine.Stephen M…
Learn MoreCancer Med Might Be Powerful Treatment for MS
THURSDAY, July 14, 2022 (HealthDay News) — A drug used “off-label” for multiple sclerosis (MS) is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found.The drug, called rituximab, is approved in the…
Learn MoreModest Increase Seen in Methadone-Involved OD Deaths in March 2020
WEDNESDAY, July 13, 2022 (HealthDay News) — There was a modest increase in methadone-involved overdose deaths in March 2020, according to a research letter published online July 13 in JAMA Psychiatry.Noting that in order to facilitate methadone acces…
Learn MoreTapinarof Effective for Longer-Term Treatment of Plaque Psoriasis
WEDNESDAY, July 13, 2022 (HealthDay News) — Four in 10 plaque psoriasis patients achieve complete disease clearance with tapinarof cream, 1 percent, according to a study published online June 26 in the Journal of the American Academy of Dermatology.B…
Learn MoreSuvorexant May Ease Symptoms During Opioid Withdrawal Therapy
TUESDAY, July 12, 2022 (HealthDay News) — For individuals with opioid use disorder undergoing a buprenorphine/naloxone taper, suvorexant might be a promising treatment for reducing sleep disturbance and easing opioid withdrawal, according to a study …
Learn MoreEl dolor de espalda en los adultos mayores: los expertos ofrecen una guía de analgésicos
VIERNES, 8 de julio de 2022 (HealthDay News) — El dolor de espalda y de cuello con frecuencia son una parte desafortunada del envejecimiento, pero los adultos mayores pueden encontrar un alivio de forma segura mediante varios medicamentos, concluye u…
Learn More